PATENT CLAIM ANALYSIS

Application Number: 16143682
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["600", "476000"]

Abstract:
In certain aspects, the invention relates to processes for using renally excretable optical agents to detect one or more tissues of the renal system of a surgical patient. In certain aspects, the invention relates to a kit including a biocompatible composition containing one or more optical agents and instructions for using the optical agent(s) in a process of the present invention.

Claim (Index 19):
The process of  claim 15 , wherein the pyrazine molecule is administered by a route selected from the group consisting of parenterally, enterally, intravenously, intraarterially, orally, gastric or intestinal feeding tube, intramuscular injection, subcutaneous injection or infusion, intraperitoneal injection or infusion, intrathecally, sublingually, rectally, vaginally, nasally, by inhalation, transdermal absorption through the skin and intraosseous infusion.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 97.0
- Lexical Diversity: 1.65854
- Patent Class: 600.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14919967', '11995270', '11721186', '14047733', '15178720']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5533181384167197
- 35 USC 102 Novelty (BERT): 0.570136747626212
- Combined Prediction Score: 0.554999999337669
- Mean Citation Score: 332.918408
- Max Citation Score: 571.0967400000002
- Similarity Product: 373.8953569876887

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test